I+D

• [2025]

The Immunogenic Tumor-Specific Neoantigen Database (ITSNdb): A Tool for Comprehensive Performance Evaluation of Neoantigen Immunogenicity Predictors

Guadalupe Nibeyro, Rocío Flesia, Daniela Orschanski, Agustín Nava, Verónica Baronetto y Elmer A Fernández. Mayo 2025. DOI: 10.1007/978-1-0716-4558-1_11

• [2025]

Immune Single-Cell Annotation by Molecular Signature-Based Deconvolution with MIXTURE

Agustin Nava, Guadalupe Nibeyro, Daniela Orschanski, Veronica Baronetto, Andrea S Llera, Elmer A Fernández. Mayo 2025. DOI: 10.1007/978-1-0716-4558-1_13

• [2025]

Mucin 4 expression is associated with metastasis in triple-negative breast cancer and can be tackled by soluble TNF blockade, improving immunotherapy outcome

Florencia Mauro, Sofía Bruni, Agustina Dupont, Aldana Schey, Agustina Badalini, Gloria Inurrigarro […] Febrero de 2025. Oncología Traslacional 54:102325. DOI: 10.1016/j.tranon.2025.102325

• [2025]

Proteomic analysis reveals candidate molecules to mediate cortical pathology and identify possible biomarkers in an animal model of multiple sclerosis

Berenice Anabel Silva, María Celeste Leal, María Isabel Farias, Agustín Nava, Daniela Inés Galván, Fernando Juan Pitossi, Carina Cintia Ferrari, Elmer Fernandez. Febrero 2025. DOI: 10.3389/fimmu.2025.1505459. LicenciaCC BY 4.0

• [2025]

Closing the gap: prognostic and predictive biomarker validation for personalized care in a Latin American hormone-dependent breast cancer cohort

Daniela Alves da Quinta, Darío Rocha, Javier Retamales, Diego Giunta, Nora Artagaveytia, Carlos Velázquez, Adrián Daneri-Navarro, Bettina Müller […] Agosto 2024. El oncólogo 29(10) DOI: 10.1093/oncolo/oyae191
LicenciaCC BY 4.0

• [2024]

Implementing Standard Diagnosis and Treatment for Locally Advanced Breast Cancer Through Global Research in Latin America: Results From a Multicountry Pragmatic Trial

Javier Retamales, Adrián Daneri-Navarro, Nora Artagaveytia, Daniela Alves da Quinta, Eliana Abdelhay
Osvaldo L. Podhajcer, Carlos Velázquez, Diego Giunta, Susanne Crocamo, Elmer A. Fernández […] Mayo 2024. JCO Global Oncology 10(10)
DOI: 10.1200/GO.23.00216